INTERNATIONAL PATENT: CORCEPT THERAPEUTICS INCORPORATED FILES APPLICATION FOR "MIRICORILANT TREATMENT FOR FATTY LIVER DISEASES AND ITS EFFECTS ON LIVER FAT CONTENT, FATTY ACIDS, ACYLGLYCEROLS, AND SECONDARY BILE ACIDS"

GENEVA, Aug. 26 -- CORCEPT THERAPEUTICS INCORPORATED (101 Redwood Shores ParkwayRedwood City, California 94065) filed a patent application (PCT/US2025/015382) for "MIRICORILANT TREATMENT FOR FATTY LIVER DISEASES and its EFFECTS on LIVER FAT CONTENT, FATTY ACIDS, ACYLGLYCEROLS, and SECONDARY BILE ACIDS" on Feb 11, 2025. With publication no. WO/2025/174745, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JUNEJA, Kavita (c/o Corcept Therapeutics Incorporated101 Redwood Shores ParkwayRedwood City, California 94065), MAYORAL M...